These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22896754)

  • 21. Antibody-directed, effector cell-mediated tumor destruction.
    Sondel PM; Hank JA
    Hematol Oncol Clin North Am; 2001 Aug; 15(4):703-21. PubMed ID: 11676280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A monoclonal antibody (B72.3) to adenocarcinoma of the colon and related tumors.
    Schlom J; Colcher D; Szpak CA; Johnston WW; Sugarbaker P; Carrasquillo JA; Reynolds JC; Larson SM
    Prog Clin Biol Res; 1989; 288():63-72. PubMed ID: 2717642
    [No Abstract]   [Full Text] [Related]  

  • 23. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
    Peggs KS; Quezada SA; Korman AJ; Allison JP
    Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies in therapy of solid tumors.
    Heimann DM; Weiner LM
    Surg Oncol Clin N Am; 2007 Oct; 16(4):775-92, viii. PubMed ID: 18022544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technology evaluation: edrecolomab, Centocor Inc.
    Abicht A; Lochmüller H
    Curr Opin Mol Ther; 2000 Oct; 2(5):593-600. PubMed ID: 11249762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of hybridoma-exchange antibodies.
    Lloyd KO; Albino A; Houghton A
    Hybridoma; 1982; 1(4):461-3. PubMed ID: 6208140
    [No Abstract]   [Full Text] [Related]  

  • 27. [Monoclonal antibodies: toward the comprehension of the cellular dynamics of the immune system].
    Piris Pinilla MA; Rivas Manga C
    Med Clin (Barc); 1984 Jun; 83(3):122-8. PubMed ID: 6237234
    [No Abstract]   [Full Text] [Related]  

  • 28. Campath-1H treatment of multiple sclerosis.
    Jones JL; Coles AJ
    Neurodegener Dis; 2008; 5(1):27-31. PubMed ID: 18075272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Target cell induced T cell activation with bispecific antibodies: a new concept for tumor immunotherapy.
    Wolf H; Freimann U; Jung G
    Recent Results Cancer Res; 1994; 135():185-95. PubMed ID: 8047693
    [No Abstract]   [Full Text] [Related]  

  • 30. Cancer immunotherapy: Progress and challenges in the clinical setting.
    Zarour HM; Ferrone S
    Eur J Immunol; 2011 Jun; 41(6):1510-5. PubMed ID: 21618503
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibodies in oncology.
    Pillay V; Gan HK; Scott AM
    N Biotechnol; 2011 Sep; 28(5):518-29. PubMed ID: 21473941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance for neurobiology and neurooncology of antigens of malignant gliomas as defined by monoclonal antibodies.
    Vrionis FD; Wikstrand CJ; Bigner DD
    Ann N Y Acad Sci; 1988; 540():64-77. PubMed ID: 2462837
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer immunotherapy and immunomonitoring (CITIM): redefining cancer therapy.
    Malyguine A; Umansky V; Shurin MR
    J Immunotoxicol; 2009 Dec; 6(4):205-8. PubMed ID: 19908938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab.
    Berek JS
    Expert Opin Biol Ther; 2004 Jul; 4(7):1159-65. PubMed ID: 15268682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An introduction to tumour immunology.
    James K
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting targeted therapies.
    Shingler W; Harrop R
    Immunotherapy; 2010 Nov; 2(6):745-8. PubMed ID: 21091104
    [No Abstract]   [Full Text] [Related]  

  • 37. Selection of phage-displayed accessible recombinant targeted antibodies (SPARTA): methodology and applications.
    D'Angelo S; Staquicini FI; Ferrara F; Staquicini DI; Sharma G; Tarleton CA; Nguyen H; Naranjo LA; Sidman RL; Arap W; Bradbury AR; Pasqualini R
    JCI Insight; 2018 May; 3(9):. PubMed ID: 29720567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basic principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation award lecture.
    Schlom J
    Cancer Res; 1986 Jul; 46(7):3225-38. PubMed ID: 3518915
    [No Abstract]   [Full Text] [Related]  

  • 39. Future directions in tumor immunotherapy: CTLA4 blockade.
    Gulley JL; Dahut WL
    Nat Clin Pract Oncol; 2007 Mar; 4(3):136-7. PubMed ID: 17327854
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antibodies against cancer].
    Barriuso Feijóo J; Sundlov A; González Barón M
    Rev Clin Esp; 2004 Dec; 204(12):649-54. PubMed ID: 15710074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.